The global Contrast Enhanced Ultrasound Market in terms of revenue was estimated to be worth $1.6 billion in 2023 and is poised to reach $2.1 billion by 2028, growing at a CAGR of 6.1% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The rising use of contrast agents, increasing partnerships and collaborations, and the introduction of novel technologies are expected to drive the market during the forecast period. The technologically advanced systems come with improved features and higher sensitivity. The novel technology helps to gain accurate results and increases diagnostic confidence.

Download a FREE Sample PDF of the Global Contrast Enhanced Ultrasound Market Research Report at https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=22947908

Prominent players in the market are GE Healthcare (US), Lantheus Holdings, Inc. (US),  Bracco Imaging SpA (Italy), and Koninklijke Philips N.V. (Netherlands).

This report has segmented the global contrast enhanced ultrasound market to forecast revenue and analyze trends in each of the following submarkets:

By Product

• Equipment
• Contrast Agents
• Molecule-targeted Microbubbles
• Nanoparticle Microbubbles
• Software and Services

By Application

• Diagnostic Applications
• Cardiology
• Hepatic/Liver
• Nephrology/Kidney
• Other Diagnostic Applications
• Therapeutic Applications
• Cardiology
• Vascular
• Oncology
• Other Therapeutic Applications

By End User

• Hospitals and Surgical Centers
• Diagnostic Imaging Clinics
• Ambulatory Surgical Centers
• Other End Users

By product, the contrast-enhanced ultrasound equipment segment accounted for the largest share of the contrast enhanced ultrasound industry in 2022.

Based on product, the global contrast enhanced ultrasound market is segmented into equipment, contrast agents, and software and services. In 2022, the equipment segment accounted for the largest market share. The rising use of advanced instruments supporting accurate diagnosis and the need for better sensitivity is driving segment growth.

By application, the therapeutic applications segment of the contrast enhanced ultrasound industry to register significant growth in the near future.

Based on application, the global contrast enhanced ultrasound market is segmented into diagnostic applications and therapeutic applications. The therapeutic applications segment registered the highest growth rate during the forecast period. The major factors responsible for the highest growth rate of this segment are the rising use of novel equipment that allows precise targeting of internal organs supporting real-time imaging.

By end user, the hospitals and surgical centers segment accounted for the largest share of the contrast enhanced ultrasound industry in 2022.

Based on end users, the global contrast enhanced ultrasound market is segmented into hospitals and surgical centers, diagnostic imaging clinics, ambulatory surgical centers, and other end users. In 2022, the hospitals and surgical centers segment accounted for the largest market share. The highest share of this segment is attributed to the rising utilization of contrast-enhanced ultrasound equipment for disease diagnosis and increasing awareness for early diagnosis. This is primarily attributed to the digitization of radiology patient workflow, the increasing number of contrast-enhanced ultrasound procedures performed in hospitals, and the rising adoption of advanced systems with improved features in hospitals to improve the quality of patient care.

Direct Purchase of the Global Contrast Enhanced Ultrasound Market Research Report at https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=22947908

By region, North America is expected to be the largest region of the contrast enhanced ultrasound industry during the forecast period.

North America, comprising the US and Canada, accounted for the largest share of the contrast enhanced ultrasound market in 2022. Factors such as increasing applications in the healthcare sector, favorable reimbursement policies for contrast-enhanced ultrasound procedures, and the presence of major players in the region are fueling the growth in North America. Rapid growth in the old age population in the region and significant utilization of contrast agents is supporting the growth of the market.